An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Name: An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
License: Public Domain

ModernaTX, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 341990
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.